市场调查报告书
商品编码
1470516
诊断心电图机市场:按产品类型、引线类型和最终用户 - 2024-2030 年全球预测Diagnostic Electrocardiograph Market by Product (Devices, Software & Services), Lead Type (12-lead, 3-lead, 5-lead), End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年诊断心电图机市场规模为112亿美元,预计2024年将达119.5亿美元,2030年将达176.1亿美元,复合年增长率为6.67%。
诊断心电图机是一种非侵入性的重要医疗设备,用于检测和监测与心臟相关的疾病和状况。该设备也称为心电图或心电图,透过放置在皮肤上的电极记录一段时间内心臟的电活动。在全球范围内,这些设备被用于医院、诊所和其他医疗机构,并且越来越多地用于远端患者监护医疗保健领域快速成长的趋势。心血管疾病的日益普及、诊断技术的进步以及远端患者监护的兴起推动了市场扩张。但面临心电图机价格高、诊断设备报销政策不足等挑战。诊断心电图机市场的未来成长机会在于透过人工智慧和机器学习的新应用越来越多地采用数位健康技术。
主要市场统计 | |
---|---|
基准年[2023] | 112亿美元 |
预测年份 [2024] | 119.5亿美元 |
预测年份 [2030] | 176.1亿美元 |
复合年增长率(%) | 6.67% |
增加产品软体和服务的使用、资料分析和准确解释
心臟事件记录器是一种用于短期心臟监测的可携式设备,可捕捉特定事件或症状。心电图监测是一种连续门诊设备,可记录较长时间(通常 24 至 48 小时)内的心臟活动。植入式循环记录器是一种皮下装置,植入后用于长期监测,特别是检测心律不整。行动心电遥测设备是能够即时传输心臟资料的无线设备,可在传统环境之外进行连续监测。静态心电图设备是用于常规、无压力评估的标准心电图设备。智慧心电图监视器整合了智慧技术,以增强连接性、资料分析和用户互动。压力心电图设备旨在监测身体压力测试期间的心臟活动。诊断心电图领域包括一套软体和服务。其中包括资料分析、解释演算法和远端医疗解决方案,可增强上述设备的诊断能力。这些产品共同建构了一种全面的诊断方法,将分析工具和服务与硬体创新相结合,以更好地了解心臟健康。
导极类型:越来越偏好12 导程心电图仪,它可以提供最详细的诊断
12 导程心电图仪通常被视为标准,因为其全面的范围可从 12 个不同角度提供心臟概况。特别是,它可以早期诊断心肌梗塞等心臟疾病,强烈建议在急诊医院使用。三导联心电图通常用于在医院病房和社区长期监测患者。由于簧片数量有限,只能观察到基本的节奏。然而,它足以检测严重的、危及生命的心律不整。 5导联心电图比3导程心电图提供更全面的讯息,使其适合重症患者和可能快速变化的紧急照护。这种引线结构可以监测节律和缺血。 6 导程心电图比 5 导程心电图稍微专业一些,通常用于需要快速详细了解心臟电活动的紧急情况。单导联心电图主要用于初步心律辨识和长期心率监测。单导联心电图通常用于在医生办公室、门诊或患者家中进行长期监测。
最终用户:随着加护病房和心臟科病房的增加,诊断心电图仪在整个医院和诊所的潜力不断增加。
门诊手术中心 (ASC) 在医疗保健行业中发挥着至关重要的作用。由于与医院相比,这些中心方便且成本较低,因此对门诊手术的高需求推动了这些中心的发展。随着 ASC 数量的增加,对包括心电图机在内的高阶、精确诊断设备的需求也在增加。诊断中心主要着重于疾病检测和预防。在这种环境中,高精度和快速结果至关重要。对远距心臟病学等方面的需求也为心电图市场提供了上升动力。医院和诊所占据了最终用户心电图市场的主要份额。加护病房、心臟科室和其他经常收治心臟病患者的医疗部门清楚地表明在这些环境中需要心电图设备。
区域洞察
凭藉技术创新和机会,美洲诊断心电图机市场预计在未来几年将显着成长。完善的医疗保健政策、对非侵入性技术不断增长的需求以及心电图机技术的持续进步使该地区成为强大的市场力量。由于对先进诊断工具的需求不断增长、人口增长和健康意识不断提高,欧洲、中东和非洲地区的心电图机市场正在增长势头。欧洲强大的医疗保健部门在先进的疾病管理通讯协定的支持下,正在推动对包括心电图机在内的准确诊断设备的需求。儘管中东和非洲市场仍处于起步阶段,但预计将快速成长,这主要得益于医疗基础设施的改善以及政府对医疗数位化介入的加强。亚太地区(APAC),尤其是快速成长的印度和中国,由于其庞大的患者基础和不断增长的医疗保健支出,正在为诊断心电图市场创造利润丰厚的机会。此外,心血管疾病的盛行率不断上升以及对先进医疗设备的大力投资是促成这一转变的特征因素。
FPNV定位矩阵
FPNV定位矩阵对于评估诊断心电图机市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对诊断心电图机市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.诊断心电图机市场规模及预测为何?
2.诊断心电图机市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3.诊断心电图机市场的技术趋势和法规结构是什么?
4.诊断心电图机市场主要厂商的市场占有率是多少?
5.进入诊断心电图市场的合适型态和策略手段是什么?
[191 Pages Report] The Diagnostic Electrocardiograph Market size was estimated at USD 11.20 billion in 2023 and expected to reach USD 11.95 billion in 2024, at a CAGR 6.67% to reach USD 17.61 billion by 2030.
A diagnostic electrocardiograph is a non-invasive, essential medical device used in detecting and monitoring heart-related diseases and conditions. Also referred to as an ECG or EKG, this device records the electrical activity of the heart over a period of time through electrodes attached to the skin. Globally, these devices are used in hospitals, clinics, and other healthcare facilities, with increased use in remote patient monitoring, a burgeoning trend in healthcare. Market expansion is propelled by the growing prevalence of cardiovascular ailments, advances in diagnostic technology, and the rise of remote patient monitoring. However, it faces challenges owing to the high cost of electrocardiographs and inadequate reimbursement policies for diagnostic devices. Future growth opportunities for the diagnostic electrocardiograph market lie in the growing adoption of digital health technology with the emerging applications of artificial intelligence and machine learning.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 11.20 billion |
Estimated Year [2024] | USD 11.95 billion |
Forecast Year [2030] | USD 17.61 billion |
CAGR (%) | 6.67% |
Product: Growing utilization of software & services or data analysis and accurate interpretation
Event monitors are portable devices for short-term cardiac monitoring, capturing specific events or symptoms. Holter monitors are continuous ambulatory devices recording heart activity over an extended period, typically 24 to 48 hours. Implantable loop recorders are subcutaneous devices implanted for long-term monitoring, especially for detecting irregular heart rhythms. Mobile cardiac telemetry devices are wireless devices that enable real-time transmission of cardiac data, providing continuous monitoring outside traditional settings. Resting ECG devices are standard electrocardiogram devices used for routine, non-stressful assessments. Smart ECG monitors integrate smart technology for enhanced connectivity, data analysis, and user interaction. Stress ECG devices are designed to monitor heart activity during physical stress tests. The diagnostic electrocardiography landscape includes a suite of software & services. These encompass data analysis, interpretation algorithms, and telemedicine solutions, enhancing the diagnostic capabilities of the devices mentioned above. Together, these products contribute to a comprehensive diagnostic approach, combining hardware innovation with analytical tools & services for a more nuanced understanding of cardiac health.
Lead Type: Growing preference for 12-lead electrocardiograph as it provides the most detailed diagnostics
The 12-lead electrocardiograph is often considered the standard as its comprehensive range offers an overview of the heart from 12 different angles. Highly recommended for acute hospital settings, it allows for early diagnosis of heart conditions, particularly myocardial infarction. The 3-lead ECG is typically utilized for monitoring patients over a prolonged timespan, often on wards or in the community. Due to the limited number of leads, only basic rhythm can be observed. However, it is sufficient for detecting any major life-threatening arrhythmias. The 5-lead ECG provides more comprehensive information than the 3-lead, making it preferred for critical care and emergency settings where rapid changes can occur. This lead structure enables monitoring of both rhythm and ischemia. The 6-lead ECG is slightly more specific than the 5-lead and is generally used in emergency situations where a quick but detailed overview of the heart's electrical activity is needed. Single-lead ECGs are primarily used for preliminary rhythm identification or long-term heart rate monitoring. They are often found in doctor's offices, outpatient settings, or patient's homes for long-term monitoring.
End-User: Increasing potential of diagnostic electrocardiographs across hospitals & clinics with increased intensive care units and cardiac units
Ambulatory surgical centers (ASCs) play a pivotal role in the healthcare industry. These centers are driven by a high demand for outpatient surgeries, given their convenience and lower cost compared to hospitals. As the number of ASCs proliferates, there is a growing requirement for high-end, precise diagnostic equipment, including Electrocardiographs. Diagnostic centers mainly revolve around disease detection and prevention. High accuracy and quick results are paramount in this setting. The need for facets, including telecardiology, has also given the ECG market an upward thrust. Hospitals & clinics form the major share of the end-user ECG market segment. The palpable necessity for ECG devices in these settings is driven by the intensive care units, cardiac units, and other medical departments that routinely cater to heart patients.
Regional Insights
Blended with innovation and lucrative opportunities, the diagnostic electrocardiograph market in the Americas is expected to grow substantially in the coming years. With the advent of crafted healthcare policies coupled with increased demand for non-invasive techniques and continuous technological advancements in electrocardiographs, this region holds a robust market stronghold. The Electrocardiograph market in the EMEA is gaining momentum, with the region's increasing demand for advanced diagnostic tools, growing population, and rising health awareness. Europe's strong healthcare sector, paved by advanced disease management protocols, is driving the demand for accurate diagnostic devices including electrocardiographs. The markets in the Middle East and Africa are at a nascent stage but are expected to burgeon, primarily owing to the improving healthcare infrastructure and increased government intervention in healthcare digitalization. The Asia-Pacific (APAC) region, particularly the fast-growing economies of India and China, is creating lucrative opportunities for the diagnostic electrocardiograph market, with their vast patient base and increasing healthcare spending. Furthermore, the increasing prevalence of cardiovascular diseases coupled with the robust investment in advanced medical equipment are distinctive factors that are contributing to this upturn.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Diagnostic Electrocardiograph Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Diagnostic Electrocardiograph Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Diagnostic Electrocardiograph Market, highlighting leading vendors and their innovative profiles. These include ACS Diagnostics, AliveCor, Inc., Ambu A/S, Aspel SA, ATsens Co., Ltd., Auxo Medical LLC, Bionet Co., Inc., BPL Medical Technologies Pvt. Ltd., BTL, Cardioline S.p.A., CompuMed, Inc., Custo Med GmbH, Davis Medical Electronics, Inc., Edan Instruments, Inc., Fukuda Denshi Co., Ltd., GE HealthCare Technologies Inc., Hill-Rom, Inc., Innomed Medical Zrt., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Nihon Kohden Corporation, Norav Medical Ltd., OSI Systems, Inc., Schiller AG, Shenzhen Comen Medical Instruments Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Suzuken Co., Ltd., Vectracor, Inc., Viatom Technology Co., Ltd., VYAIRE Medical, Inc., and Zimmer MedizinSysteme GmbH.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Diagnostic Electrocardiograph Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Diagnostic Electrocardiograph Market?
3. What are the technology trends and regulatory frameworks in the Diagnostic Electrocardiograph Market?
4. What is the market share of the leading vendors in the Diagnostic Electrocardiograph Market?
5. Which modes and strategic moves are suitable for entering the Diagnostic Electrocardiograph Market?